(Q43803092)

27 November 2017

Dramatic worsening of type 2 diabetes mellitus due to olanzapine after 3 years of therapy (English)

1 reference

27 November 2017

1 reference

C I Bechara

1

1 reference

27 November 2017

J D Goldman-Levine

series ordinal

2

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

27 November 2017

1 reference

27 November 2017

21

1 reference

27 November 2017

11

1 reference

27 November 2017

1444-1447

1 reference

Olanzapine-induced glucose dysregulation.

27 November 2017

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1444.34423

Olanzapine-lnduced hyperglycemic nonketonic coma

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1444.34423

Olanzapine-induced diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1444.34423

Diabetes mellitus in schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1444.34423

A method for estimating the probability of adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1444.34423

Peripheral glucose metabolism in human hyperprolactinaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1444.34423

The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.21.17.1444.34423

10.1592/PHCO.21.17.1444.34423

21 January 2018

Identifiers

DOI

1 reference

release_pkdc4usuevfl3crzqdjp57ohdy

27 November 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pkdc4usuevfl3crzqdjp57ohdy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference